103 related articles for article (PubMed ID: 29600977)
1. Characterization of the cytotoxic effects of the combination of cisplatin and flavanol (-)-epicatechin on human lung cancer cell line A549. An isobolographic approach.
Varela-Castillo O; Cordero P; Gutiérrez-Iglesias G; Palma I; Rubio-Gayosso I; Meaney E; Ramirez-Sanchez I; Villarreal F; Ceballos G; Nájera N
Exp Oncol; 2018 Mar; 40(1):19-23. PubMed ID: 29600977
[TBL] [Abstract][Full Text] [Related]
2. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells].
Zhong H; Zuo Y; Wu X; Peng Y; He H; Yang J; Guan C; Xu Z
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):805-812. PubMed ID: 27978865
[TBL] [Abstract][Full Text] [Related]
4. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells).
Kalai Selvi S; Vinoth A; Varadharajan T; Weng CF; Vijaya Padma V
Food Chem Toxicol; 2017 May; 103():28-40. PubMed ID: 28223119
[TBL] [Abstract][Full Text] [Related]
5. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
6. [Effect of cisplatin alone or combined with monoclonal anti-programmed death ligand-1 antibody on lung adenocarcinoma cell line SPCA-1 and T lymphocytes].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):416-20. PubMed ID: 25200040
[TBL] [Abstract][Full Text] [Related]
7. rmhTNF-α combined with cisplatin inhibits proliferation of A549 cell line in vitro.
Xia LM; Zhou YY
Chin Med Sci J; 2014 Sep; 29(3):185-7. PubMed ID: 25264888
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
Abdulrahman N; Siveen KS; Joseph JM; Osman A; Yalcin HC; Hasan A; Uddin S; Mraiche F
J Pharm Pharmacol; 2020 Nov; 72(11):1536-1545. PubMed ID: 32667058
[TBL] [Abstract][Full Text] [Related]
9. Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549.
Shen F; Gai J; Xing J; Guan J; Fu L; Li Q
Biochem Biophys Res Commun; 2018 Jan; 495(1):1158-1166. PubMed ID: 29175207
[TBL] [Abstract][Full Text] [Related]
10. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
13. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
Zhang X; Li Q; Han Y; Liu Z
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
[TBL] [Abstract][Full Text] [Related]
14. Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin.
Tseng CY; Lin CH; Wu LY; Wang JS; Chung MC; Chang JF; Chao MW
PLoS One; 2016; 11(5):e0155469. PubMed ID: 27171432
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299.
Huang JQ; Liang HL; Zhang XC; Xie Z; Jin TE
Asia Pac J Clin Oncol; 2016 Mar; 12(1):41-51. PubMed ID: 26620316
[TBL] [Abstract][Full Text] [Related]
16. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.
Liang H; Wang HB; Liu HZ; Wen XJ; Zhou QL; Yang CX
Biomed Pharmacother; 2013 Jul; 67(6):503-9. PubMed ID: 23639227
[TBL] [Abstract][Full Text] [Related]
17. [Tumstatin185-191 increases the sensitivity to cisplatin in a cisplatin-resistant human lung adenocarcinoma cell line].
Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):577-81. PubMed ID: 20021943
[TBL] [Abstract][Full Text] [Related]
18. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A; Marchat LA; Sánchez LL; Romero-Zamora D; Arechaga-Ocampo E; Ramírez-Torres N; Chávez JD; Carlos-Reyes Á; Astudillo-de la Vega H; Ruiz-García E; González-Pérez A; López-Camarillo C
Proteomics Clin Appl; 2016 Feb; 10(2):172-82. PubMed ID: 26175166
[TBL] [Abstract][Full Text] [Related]
19. Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line.
Xu Y; Jiang N; Yu H
Toxicol Mech Methods; 2010 Oct; 20(8):487-92. PubMed ID: 20843266
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Chen XQ; Wang YL; Li ZY; Lin TY
Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]